Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
BCRX
BCRX
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
BCRX News
Vertex's $10B Crinetics Acquisition Sparks Biotech M&A Speculation
7h ago
stocktwits
Crinetics Hits Record High After Vertex's $10 Billion Acquisition
9h ago
stocktwits
Crinetics Hits Record High After Vertex Acquisition Deal
9h ago
Yahoo Finance
BioCryst Accelerates Rare Disease Pipeline Growth Through Strategic Shift
Jun 29 2026
Newsfilter
BioCryst Pharmaceuticals Shares Surge Amid Positive Therapy Data
Jun 25 2026
stocktwits
Bitdeer and BioCryst Options Trading Activity Surges
Jun 24 2026
NASDAQ.COM
BioCryst Releases New Data on ORLADEYO and Navenibart
Jun 12 2026
NASDAQ.COM
BioCryst Reaffirms ORLADEYO Revenue Guidance Amid Navenibart Trial Progress
Jun 06 2026
Yahoo Finance
BioCryst Pharmaceuticals Q1 2026 Earnings Call Highlights
May 06 2026
seekingalpha
BioCryst Pharmaceuticals Q1 Earnings Analysis
May 06 2026
seekingalpha
BioCryst Pharmaceuticals to Announce Q1 Earnings on May 6
May 05 2026
seekingalpha
BioCryst Appoints New Chief R&D Officer to Drive Rare Disease Strategy
Apr 06 2026
Newsfilter
Rising Oil Prices and Middle East Tensions Impact Market Sentiment
Mar 24 2026
stocktwits
BioCryst Shares Surge in After-Hours Trading Amid Speculation of Major Pharma Interest — Retail Sentiment Reaches Highest Level Since 2026
Mar 24 2026
stocktwits
BioCryst Pharmaceuticals (BCRX) Shares Surge 15% Amid Takeover Speculation
Mar 16 2026
seekingalpha
BioCryst Pharmaceuticals Acquires Astria, Enhancing Market Position
Feb 27 2026
Yahoo Finance
Show More News
